UVicSpace

Targeted disruption of the gene for pituitary adenylate cyclase-activating polypeptide (PACAP) in mouse results in metabolic dysfunction.

Show simple item record

dc.contributor.author Gray, Sarah Louise
dc.date.accessioned 2018-11-08T00:52:00Z
dc.date.available 2018-11-08T00:52:00Z
dc.date.copyright 2002 en_US
dc.date.issued 2018-11-07
dc.identifier.uri https://dspace.library.uvic.ca//handle/1828/10266
dc.description.abstract A recently discovered peptide hormone, pituitary adenylate cyclase-activating polypeptide (PACAP) regulates several endocrine systems affecting essential physiological processes such as metabolism, growth, reproduction, and the stress response. PACAP acts as a hypophysiotropic factor, is a potent secretogogue of insulin, regulates production and release of catecholamines from the adrenal medulla and acts as a neuromodulator in the sympathetic and parasympathetic nervous system. The primary structure of PACAP has been highly conserved during the evolution of chordates suggesting it plays an important physiological role. The objective of my thesis was to identify PACAP’s primary physiological function and to determine if it is essential for survival by generating a mouse line deficient in PACAP through targeted disruption of the PACAP gene locus. Postnatal PACAP expression was examined to determine sites of peripheral PACAP production. In addition, several splice variants of the PACAP gene with alternate 5’untranslated regions were identified suggesting a complex system for regulating expression of the mouse PACAP gene. A targeting vector that allows tissue specific or developmental stage specific knockout of the PACAP gene was constructed in the event that PACAP gene deletion resulted in embryonic lethality. PACAP null mice were generated from homologously recombined embryonic stem cells. Initial characterization of the PACAP null mice determined that in the absence of PACAP, mice died within the first two postnatal weeks with abnormal lipid metabolism. Lipid accumulation was present in liver, heart and skeletal muscle and serum lipids were high. Mitochondrial dysfunction in the liver was not the cause of the lipid accumulation, as P-oxidative function was normal. I conclude that PACAP null mice are unable to regulate lipid release from white adipose tissue stores, resulting in a flood of lipids to non-adipose tissues. The abnormal distribution of lipids observed in the PACAP null mice is characteristic of diabetes type 2, yet classical insulin resistance is not observed. Thus, elevated insulin levels were accompanied by low blood glucose levels and the response to a glucose challenge was normal. The uncontrolled release of free fatty acids may result if glucose that is taken up by cells can not be utilized and an alternate energy source is required or if white adipocytes only are insulin resistant. The PACAP null mice were temperature sensitive, in that when raised at 21“C they exhibited metabolic dysfunction and died by two weeks of age. At 24°C most (85%) of the mice survived to adulthood with no obvious signs of metabolic dysfunction. We have determined that the inability of the PACAP null pups to thermoregulate normally when exposed to a lower environmental temperature may be associated with decreased norepinephrine levels to the brown adipose tissue. PACAP may be important for the production and release of catecholamines in the adrenal gland or within the sympathetic nervous system in times of prolonged stress. A mechanistic connection between the lipid abnormalities and the temperature sensitivity in the PACAP null pups has yet to be made. Catecholamines affect a wide range of tissues and the problems associated with insulin regulation within the PACAP null mice may be due to the imbalance in catecholamine production. As one of two main stress response systems, the sympathetic nervous system elicits a vital coping mechanism in times of stress and PACAP’s ability to regulate this system may explain why the primary structure of PACAP has remained so highly conserved. PACAP is a wide acting hormone and therefore the metabolic problems seen in the PACAP null mice may result from altered regulation of several endocrine systems at once. Targeted disruption of the PACAP gene in mouse has revealed a role for PACAP in the regulation of lipid metabolism and in the sympathetic control of thermoregulation. en_US
dc.language English eng
dc.language.iso en en_US
dc.rights Available to the World Wide Web en_US
dc.subject Hormones en_US
dc.subject Physiological effect en_US
dc.subject Endocrine genetics en_US
dc.title Targeted disruption of the gene for pituitary adenylate cyclase-activating polypeptide (PACAP) in mouse results in metabolic dysfunction. en_US
dc.type Thesis en_US
dc.contributor.supervisor Sherwood, Nancy
dc.degree.department Department of Biology en_US
dc.degree.level Doctor of Philosophy Ph.D. en_US
dc.description.scholarlevel Graduate en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search UVicSpace


Browse

My Account

Statistics

Help